Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
71 /100
HIGH RISK
Score updated Oct 13, 2026

ONCY — Oncolytics Biotech Inc. Dilution Risk Tracker

Track ONCY dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ONCY — Get alerts when the score changes →

As of October 13, 2026, Oncolytics Biotech Inc. (ONCY) has a DilutionWatch DilutionScore of 71/100, rated HIGH dilution risk. Oncolytics Biotech Inc. has a market capitalization of $60.31M, 127.51M shares outstanding, 60 institutional holders tracked. Stored dilution-related fields include 7.67M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
66
💰 Cash Runway
95
📊 Float Risk
2
⚠️ Warrant Exposure
30
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 54%
🔄 Reverse Split model est. 70%
• 50-day avg $0.94 below $1 exchange minimum
• Only 2 months cash — financial pressure
💰 Capital Raise model 55%
• Critical: only 1.6 months cash remaining
📜 Warrant Exercise model 15%
• Warrant overhang: 6.0% of shares outstanding
🔔 Track ONCY — Get forecast alerts →

Market Data

Market Cap$60.31M
Shares Outstanding127.51M
Float113.67M
Cash$4.12M
Debt$563.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore71/100DilutionWatch score record
Shares Outstanding127.51MVerified float table or market cache
Public Float113.67MVerified float table or market cache
Market Cap$60.31MMarket data cache
Cash Runway1.6 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants7.67MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 42.9% shares (2026Q1 vs prior)
60 institutional holders · 4.01M shares
#1 MORGAN STANLEY 837.9K shares
#2 RENAISSANCE TECHNOLOGIES LLC 715.8K shares
#3 Sandbox Financial Partners, LLC 400.0K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest7.37M
Days to Cover7.2
% of Float6.5%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-12
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ONCY Dilution Snapshot

Oncolytics Biotech Inc. (ONCY) has a DilutionScore of 71/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ONCY's DilutionScore is currently 71/100 (High risk), with 2 score changes tracked over 89 days. The score deteriorated from 72/100 (High risk).

Period Score Risk Level Duration
Sep 28 – Oct 13, 202671/100HIGH16 days
Aug 22 – Sep 27, 202672/100HIGH37 days
Jul 16 – Aug 21, 202669/100HIGH36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ONCY shares outstanding have increased 7.9% from 107.61M (Mar 2026) to 116.13M (Apr 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Apr 07, 2026116.13M113.67M▲ 9.59%
Mar 15, 2026107.61M103.72M▼ 0.01%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ONCY Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ONCY files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ONCY — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ONCY
ONCY FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.